Unknown

Dataset Information

0

SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.


ABSTRACT: Global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues unabated. Binding of SARS-CoV-2's Spike protein to host angiotensin converting enzyme 2 triggers viral entry, but other proteins may participate, including neuropilin-1 receptor (NRP-1). As both Spike protein and vascular endothelial growth factor-A (VEGF-A) - a pro-nociceptive and angiogenic factor, bind NRP-1, we tested if Spike could block VEGF-A/NRP-1 signaling. VEGF-A-triggered sensory neuronal firing was blocked by Spike protein and NRP-1 inhibitor EG00229. Pro-nociceptive behaviors of VEGF-A were similarly blocked via suppression of spontaneous spinal synaptic activity and reduction of electrogenic currents in sensory neurons. Remarkably, preventing VEGF-A/NRP-1 signaling was antiallodynic in a neuropathic pain model. A 'silencing' of pain via subversion of VEGF-A/NRP-1 signaling may underlie increased disease transmission in asymptomatic individuals.

SUBMITTER: Moutal A 

PROVIDER: S-EPMC7457601 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7737878 | biostudies-literature
| S-SCDT-EMM-2021-14844 | biostudies-other
| EMPIAR-10947 | biostudies-other
| S-EPMC8669939 | biostudies-literature
| EMPIAR-10891 | biostudies-other
| S-EPMC9081906 | biostudies-literature
| EMPIAR-10951 | biostudies-other
| EMPIAR-10952 | biostudies-other
| EMPIAR-11181 | biostudies-other
| EMPIAR-10516 | biostudies-other